CRISPR and Genome Editing – Products

The clinical success of CAR T-cell therapy has spurred increased interest and investments in the advanced therapeutics industry.

Download this whitepaper to learn more about improving AAV yield and purity using affinity resins as well as how affinity purification can contribute to viral clearance.

Comprehensive disease modeling can be challenging for many labs due to variations in reagents, cell culture conditions, technical inconsistencies across protocols and experiments and bandwidth limitations.

INTEGRA Biosciences has collaborated closely with MACHEREY-NAGEL to develop automated protocols for a variety of NucleoSpin® RNA and DNA extraction and purification kits on the ASSIST PLUS pipetting robot.

DeNovix Inc has developed two dedicated nuclei counting apps capable of differentiating isolated nuclei and intact cells from debris.

AMSBIO offers a range of lentivirus production services to provide tailor-made products to support your research.

ERS Genomics Limited is pleased to announce a new license agreement with Lepton Pharmaceuticals LTD.

TetraScience has announced the evolution of its data cloud to include manufacturing and quality control data.

MaxCyte, Inc. has announced the signing of a strategic platform license with LG Chem Ltd.

In recent years, interest in lipid nanoparticle (LNP) research has increased due to promising opportunities for RNA-based therapy and gene-editing technology, and LNPs are showing promise as nucleic acid delivery vehicles in the pharmaceutical industry.